Basic gene annotations are collected from Uniprot
and displayed with links to original sources. A quick link to explore the genomic context with Uniprot Browser
is available.
POU2F3 - POU class 2 homeobox 3
Function
Transcription factor that binds to the octamer motif (5'-ATTTGCAT-3') and regulates cell type-specific differentiation pathways. Involved in the regulation of keratinocytes differentiation (PubMed:11329378). The POU2F3-POU2AF2/POU2AF3 complex drives the expression of tuft-cell-specific genes, a rare chemosensory cells that coordinate immune and neural functions within mucosal epithelial tissues (PubMed:35576971).
Uniprot BrowserEntrez ID | EnsEMBL ID | Preferred Name | Uniprot ID |
---|---|---|---|
25833 | ENSG00000137709 | POU2F3 | Q9UKI9 |
Causal Flows
are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow, a mutation
may causally activate or deactivate a downstream regulator
which then might up- down-regulates a regulon
that contains genes with similar expression profiles and binding sites.
Causal Mechanistic Flows with ENSG00000137709 as Regulator
ID | Mutation | Role | Regulator | Role | Regulon | # downstream regulons | # diffexp regulons | Drugs |
---|---|---|---|---|---|---|---|---|
CMF-00187 | PCLO | down-regulates | POU2F3 | represses | R-1707 | 16 | 2 | Drugs (10) Regulator Drugs (0)Regulon Drugs (10)AMG-780, MEDI-3617, ENIBARCIMAB, F16SIP 131I, TREBANANIB, F16IL2, VANUCIZUMAB, FARICIMAB, CVX-060, NESVACUMAB |
CMF-00960 | TPTE | down-regulates | POU2F3 | represses | R-1707 | 16 | 4 | Drugs (10) Regulator Drugs (0)Regulon Drugs (10)AMG-780, MEDI-3617, ENIBARCIMAB, F16SIP 131I, TREBANANIB, F16IL2, VANUCIZUMAB, FARICIMAB, CVX-060, NESVACUMAB |
CMF-03778 | DSP | down-regulates | POU2F3 | represses | R-1706 | 16 | 12 | Drugs (1) |
CMF-05486 | IL18RAP | down-regulates | POU2F3 | represses | R-1706 | 16 | 3 | Drugs (1) |
CMF-05952 | SLC9A4 | down-regulates | POU2F3 | represses | R-1707 | 16 | 1 | Drugs (10) Regulator Drugs (0)Regulon Drugs (10)AMG-780, MEDI-3617, ENIBARCIMAB, F16SIP 131I, TREBANANIB, F16IL2, VANUCIZUMAB, FARICIMAB, CVX-060, NESVACUMAB |
CMF-06472 | LGSN | down-regulates | POU2F3 | represses | R-1707 | 16 | 3 | Drugs (10) Regulator Drugs (0)Regulon Drugs (10)AMG-780, MEDI-3617, ENIBARCIMAB, F16SIP 131I, TREBANANIB, F16IL2, VANUCIZUMAB, FARICIMAB, CVX-060, NESVACUMAB |
CMF-08332 | AFM | down-regulates | POU2F3 | represses | R-1707 | 16 | 4 | Drugs (10) Regulator Drugs (0)Regulon Drugs (10)AMG-780, MEDI-3617, ENIBARCIMAB, F16SIP 131I, TREBANANIB, F16IL2, VANUCIZUMAB, FARICIMAB, CVX-060, NESVACUMAB |
CMF-08520 | MYO3A | down-regulates | POU2F3 | represses | R-1706 | 16 | 5 | Drugs (1) |
CMF-09374 | CUL1 | down-regulates | POU2F3 | represses | R-1707 | 16 | 3 | Drugs (10) Regulator Drugs (0)Regulon Drugs (10)AMG-780, MEDI-3617, ENIBARCIMAB, F16SIP 131I, TREBANANIB, F16IL2, VANUCIZUMAB, FARICIMAB, CVX-060, NESVACUMAB |
CMF-13427 | FMN1 | down-regulates | POU2F3 | represses | R-1706 | 16 | 4 | Drugs (1) |
CMF-13428 | FMN1 | down-regulates | POU2F3 | represses | R-1707 | 16 | 4 | Drugs (10) Regulator Drugs (0)Regulon Drugs (10)AMG-780, MEDI-3617, ENIBARCIMAB, F16SIP 131I, TREBANANIB, F16IL2, VANUCIZUMAB, FARICIMAB, CVX-060, NESVACUMAB |
CMF-16047 | NFIX | down-regulates | POU2F3 | represses | R-1706 | 16 | 5 | Drugs (1) |
CMF-16513 | SEZ6L2 | down-regulates | POU2F3 | represses | R-1707 | 16 | 1 | Drugs (10) Regulator Drugs (0)Regulon Drugs (10)AMG-780, MEDI-3617, ENIBARCIMAB, F16SIP 131I, TREBANANIB, F16IL2, VANUCIZUMAB, FARICIMAB, CVX-060, NESVACUMAB |
CMF-17295 | SYNJ2 | down-regulates | POU2F3 | represses | R-1706 | 16 | 2 | Drugs (1) |
CMF-17296 | SYNJ2 | down-regulates | POU2F3 | represses | R-1707 | 16 | 2 | Drugs (10) Regulator Drugs (0)Regulon Drugs (10)AMG-780, MEDI-3617, ENIBARCIMAB, F16SIP 131I, TREBANANIB, F16IL2, VANUCIZUMAB, FARICIMAB, CVX-060, NESVACUMAB |
CMF-19025 | UPF1 | down-regulates | POU2F3 | represses | R-1706 | 16 | 4 | Drugs (1) |
CMF-19621 | CDHR3 | down-regulates | POU2F3 | represses | R-1707 | 16 | 1 | Drugs (10) Regulator Drugs (0)Regulon Drugs (10)AMG-780, MEDI-3617, ENIBARCIMAB, F16SIP 131I, TREBANANIB, F16IL2, VANUCIZUMAB, FARICIMAB, CVX-060, NESVACUMAB |
CMF-20388 | CUX2 | down-regulates | POU2F3 | represses | R-1707 | 16 | 5 | Drugs (10) Regulator Drugs (0)Regulon Drugs (10)AMG-780, MEDI-3617, ENIBARCIMAB, F16SIP 131I, TREBANANIB, F16IL2, VANUCIZUMAB, FARICIMAB, CVX-060, NESVACUMAB |
CMF-22418 | IDH1 | down-regulates | POU2F3 | represses | R-1706 | 16 | 6 | Drugs (1) |
CMF-24155 | HEATR5A | down-regulates | POU2F3 | represses | R-1707 | 16 | 2 | Drugs (10) Regulator Drugs (0)Regulon Drugs (10)AMG-780, MEDI-3617, ENIBARCIMAB, F16SIP 131I, TREBANANIB, F16IL2, VANUCIZUMAB, FARICIMAB, CVX-060, NESVACUMAB |
CMF-24719 | SLC4A5 | down-regulates | POU2F3 | represses | R-1707 | 16 | 1 | Drugs (10) Regulator Drugs (0)Regulon Drugs (10)AMG-780, MEDI-3617, ENIBARCIMAB, F16SIP 131I, TREBANANIB, F16IL2, VANUCIZUMAB, FARICIMAB, CVX-060, NESVACUMAB |
CMF-26039 | PITX2 | down-regulates | POU2F3 | represses | R-1707 | 16 | 1 | Drugs (10) Regulator Drugs (0)Regulon Drugs (10)AMG-780, MEDI-3617, ENIBARCIMAB, F16SIP 131I, TREBANANIB, F16IL2, VANUCIZUMAB, FARICIMAB, CVX-060, NESVACUMAB |
CMF-28543 | SNTG2 | down-regulates | POU2F3 | represses | R-1706 | 16 | 4 | Drugs (1) |